These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 34782310)
1. [Biomarkers in diabetes mellitus: contributions and discrepancies of new technologies. A case report]. Mialon F; Catargi B; Rami L; Barat P; Bedel A; Lacape G; Bérard AM; Beauvieux MC Ann Biol Clin (Paris); 2021 Oct; 79(5):445-451. PubMed ID: 34782310 [TBL] [Abstract][Full Text] [Related]
2. Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need? Fabris C; Heinemann L; Beck R; Cobelli C; Kovatchev B Diabetes Technol Ther; 2020 Jul; 22(7):501-508. PubMed ID: 32459124 [No Abstract] [Full Text] [Related]
3. "Mind the gap please…": estimated vs. measured A Oriot P; Hermans MP Acta Clin Belg; 2020 Apr; 75(2):109-115. PubMed ID: 30596337 [No Abstract] [Full Text] [Related]
5. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus. Gurnurkar S; Owens L; Chalise S; Vyas N J Pediatr Endocrinol Metab; 2021 Mar; 34(3):311-317. PubMed ID: 33618445 [TBL] [Abstract][Full Text] [Related]
6. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL. Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500 [TBL] [Abstract][Full Text] [Related]
7. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ; JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683 [TBL] [Abstract][Full Text] [Related]
9. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes. Vigersky RA; McMahon C Diabetes Technol Ther; 2019 Feb; 21(2):81-85. PubMed ID: 30575414 [TBL] [Abstract][Full Text] [Related]
10. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Bergenstal RM; Beck RW; Close KL; Grunberger G; Sacks DB; Kowalski A; Brown AS; Heinemann L; Aleppo G; Ryan DB; Riddlesworth TD; Cefalu WT Diabetes Care; 2018 Nov; 41(11):2275-2280. PubMed ID: 30224348 [TBL] [Abstract][Full Text] [Related]
11. Accuracy and robustness of dynamical tracking of average glycemia (A1c) to provide real-time estimation of hemoglobin A1c using routine self-monitored blood glucose data. Kovatchev BP; Flacke F; Sieber J; Breton MD Diabetes Technol Ther; 2014 May; 16(5):303-9. PubMed ID: 24299302 [TBL] [Abstract][Full Text] [Related]
12. Hemoglobin A1c and Self-Monitored Average Glucose: Validation of the Dynamical Tracking eA1c Algorithm in Type 1 Diabetes. Kovatchev BP; Breton MD J Diabetes Sci Technol; 2015 Nov; 10(2):330-5. PubMed ID: 26553023 [TBL] [Abstract][Full Text] [Related]
13. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes. Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502 [TBL] [Abstract][Full Text] [Related]
15. The Fallacy of Average: How Using HbA Beck RW; Connor CG; Mullen DM; Wesley DM; Bergenstal RM Diabetes Care; 2017 Aug; 40(8):994-999. PubMed ID: 28733374 [TBL] [Abstract][Full Text] [Related]
16. Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study. Petersson J; Åkesson K; Sundberg F; Särnblad S Pediatr Diabetes; 2019 May; 20(3):339-344. PubMed ID: 30652407 [TBL] [Abstract][Full Text] [Related]
17. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes. Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102 [TBL] [Abstract][Full Text] [Related]
18. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes. Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I Endocr J; 2020 Oct; 67(10):1055-1062. PubMed ID: 32565500 [TBL] [Abstract][Full Text] [Related]
19. Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control. Yoo JH; Kim JH Diabetes Metab J; 2020 Dec; 44(6):828-839. PubMed ID: 33389957 [TBL] [Abstract][Full Text] [Related]
20. A Kinetic Model for Glucose Levels and Hemoglobin A1c Provides a Novel Tool for Individualized Diabetes Management. Xu Y; Dunn TC; Ajjan RA J Diabetes Sci Technol; 2021 Mar; 15(2):294-302. PubMed ID: 31910672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]